Compare DARE & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DARE | BFRI |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2M | 16.3M |
| IPO Year | 2014 | 2021 |
| Metric | DARE | BFRI |
|---|---|---|
| Price | $0.93 | $1.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $10.00 | $2.75 |
| AVG Volume (30 Days) | 188.5K | ★ 364.9K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 67.70 |
| EPS | ★ N/A | N/A |
| Revenue | $2,807,885.00 | ★ $41,705,000.00 |
| Revenue This Year | $2,115.12 | $14.36 |
| Revenue Next Year | $122.62 | $16.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $1.13 | $0.57 |
| 52 Week High | $3.78 | $1.40 |
| Indicator | DARE | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 25.74 | 67.98 |
| Support Level | N/A | $0.77 |
| Resistance Level | $2.14 | N/A |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 16.31 | 80.25 |
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.